OSE Immunotherapeutics' Board of Directors Proposes the Appointment of Eric Leire, MD, as New Independent Director Seite 1
31.05.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Board of Directors, upon the proposal of the Nomination and Remuneration Committee, has proposed Eric Leire, MD, as an independent Director of the ... Seite 1
Source: wallstreet-online.de